New Global Network Improves Access to Diagnostic Insights

GDN initiatives will benefit patients, healthcare providers, referring practitioners, pharmaceutical innovators, government agencies, non-governmental organizations (NGOs), and academic institutions. Starting priority areas of focus include a global launch platform for high quality companion diagnostics and the creation of an emerging pathogen preparedness network in order to expedite infectious disease research and response. Additional initiatives will be rolled out based on regional and global priorities.

“The Global Diagnostics Network will help solve some of the world's most pressing healthcare challenges by enabling fast and consistent access to leading diagnostic innovations and best practices,” said Steve Rusckowski, chairman, president, and CEO of Quest Diagnostics. “As we met with regional lab leaders over the past year, it became clear that we can accelerate the development and delivery of advanced diagnostics and diagnostic insights by bringing together our peers and sharing best practices.”

“The GDN collaboration will open up new opportunities by removing silos around unique knowledge and resources,” said Carrie Eglinton Manner, senior VP of advanced diagnostics at Quest Diagnostics. “We see this as a pragmatic approach to driving growth and excellence for all network members, while providing customers global access to innovations in diagnostics science, information, and service delivery.”

In addition to Quest Diagnostics, charter members of the GDN are Al Borg Medical Laboratories (Jeddah, Saudi Arabia), Dasa (Sao Paolo, Brazil), GC Labs (Yongin-Si, South Korea), KingMed Diagnostics (Hong Kong, China), Primary Health Care (Sydney, Australia), and SYNLAB (Munich, Germany).

Related Links:
Quest Diagnostics
Global Diagnostics Network